Insight Molecular Diagnostics (IMDX) Current Leases (2016 - 2023)

Insight Molecular Diagnostics' (IMDX) quarterly Current Leases came in at $628000.0 in Q4 2023, up 156.33% quarter-over-quarter from $245000.0 in Q2 2019.

Insight Molecular Diagnostics (IMDX) Current Leases (2016 - 2023) Analysis & Trends

Insight Molecular Diagnostics has disclosed Current Leases across 5 years of filings, most recently posting $628000.0 for Q4 2023.

  • Current Leases for Q4 2023 came in at $628000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $628000.0 (changed N/A YoY), and the FY2023 annual result was $628000.0, changed N/A from the prior year.
  • Current Leases came in at $628000.0 for Q4 2023 at Insight Molecular Diagnostics, up from $245000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $628000.0 in Q4 2023 to a low of $245000.0 in Q2 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Waters 30,529.42 Bn 30,528.96 Bn 1.11 Bn 53.00 Mn
2 Thermo Fisher Scientific 183.75 Bn 180.50 Bn 7.74 Bn -
3 Danaher 133.13 Bn 127.43 Bn 3.59 Bn -
4 Idexx Laboratories 46.14 Bn 45.94 Bn 722.74 Mn -
5 Agilent Technologies 38.20 Bn 36.39 Bn 990.00 Mn -
6 Natera 31.50 Bn 30.40 Bn 696.04 Mn -
7 Iqvia Holdings 31.34 Bn 29.36 Bn 1.36 Bn -
8 Illumina 24.51 Bn 23.36 Bn 721.00 Mn -
9 Mettler Toledo International 23.53 Bn 23.47 Bn 555.82 Mn -
10 Insight Molecular Diagnostics 4.52 Mn -24.41 Mn 15,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2023 628,000.00
Jun 30, 2019 245,000.00
Mar 31, 2019 304,000.00
Dec 31, 2018 385,000.00
Sep 30, 2018 471,000.00
Jun 30, 2018 310,000.00
Mar 31, 2018 346,000.00
Dec 31, 2017 338,000.00
Sep 30, 2017 304,000.00
Jun 30, 2017 297,000.00
Mar 31, 2017 202,000.00
Dec 31, 2016 202,000.00
Sep 30, 2016 173,000.00
Jun 30, 2016 173,000.00